Articles dans des revues avec comité de lecture (257)

  1. 23. Godin, L., Balsat, C., Van Eycke, Y.-R., Allard, J., Royer, C., Remmelink, M., Pastushenko, I., D'Haene, N., Blanpain, C., Salmon, I., Rorive, S., & Decaestecker, C. (2020). A Novel Approach for Quantifying Cancer Cells Showing Hybrid Epithelial/Mesenchymal States in Large Series of Tissue Samples: Towards a New Prognostic Marker. Cancers, 12(4), 906. doi:10.3390/cancers12040906
  2. 24. Verocq, C., Decaestecker, C., Rocq, L., De Clercq, S., Verrellen, A., Mekinda Ngono, Z. L., Ocak, S., Compere, C., Stanciu-Pop, C., Salmon, I., Remmelink, M., & D'Haene, N. (2020). The daily practice reality of PD-L1 (CD274) evaluation in non-small cell lung cancer: A retrospective study. Oncology Letters, 19(5), 3400-3410. doi:10.3892/ol.2020.11458
  3. 25. Gevaert, T., Van Eycke, Y.-R., Vanden Broeck, T., Van Poppel, H., Salmon, I., Rorive, S., Muilwijk, T., Claessens, F., De Ridder, D., Joniau, S., & Decaestecker, C. (2020). The potential of tumour microenvironment markers to stratify the risk of recurrence in prostate cancer patients. PloS one, 15(12), e0244663. doi:10.1371/journal.pone.0244663
  4. 26. Van Eycke, Y.-R., Foucart, A., & Decaestecker, C. (2019). Strategies to Reduce the Expert Supervision Required for Deep Learning-Based Segmentation of Histopathological Images. Frontiers in Medicine, 6, 222. doi:10.3389/fmed.2019.00222
  5. 27. Peerboccus, M., Van Eycke, Y.-R., Gyssels, E., Verset, L., Lucchesi, P., Absil, J., Chao, S.-L., Decaestecker, C., Van Laethem, J.-L., Metens, T., & Bali, M. A. (2019). Volumetric-Based Analysis of In-Vivo and Ex-Vivo Quantitative MR Diffusion Parameters in Pancreatic Adenocarcinoma: Correlation with Pathologic Findings. Japanese Journal of Gastroenterology and Hepatology, 1(4), 1-8.
  6. 28. Lebrun, L., Milowich, D., Le Mercier, M., Allard, J., Van Eycke, Y.-R., Roumeguere, T., Decaestecker, C., Salmon, I., & Rorive, S. (2018). UCA1 overexpression is associated with less aggressive subtypes of bladder cancer. Oncology Reports, 40(5), 2497-2506. doi:10.3892/or.2018.6697
  7. 29. D'Haene, N., Koopmansch, C., Van Eycke, Y.-R., Hulet, F., Allard, J., Bouri, S., Rorive, S., Remmelink, M., Decaestecker, C., Maris, C., & Salmon, I. (2018). The Prognostic Value of the Combination of Low VEGFR-1 and High VEGFR-2 Expression in Endothelial Cells of Colorectal Cancer. International journal of molecular sciences, 19(11), 3536. doi:10.3390/ijms19113536
  8. 30. Van Eycke, Y.-R., Balsat, C., Verset, L., Debeir, O., Salmon, I., & Decaestecker, C. (2018). Segmentation of glandular epithelium in colorectal tumours to automatically compartmentalise IHC biomarker quantification: a deep learning approach. Medical image analysis, 49, 35-45. doi:10.1016/j.media.2018.07.004
  9. 31. Gevaert, T., Van Eycke, Y.-R., Vanden Broeck, T., Van Poppel, H., Salmon, I., Rorive, S., Claessens, F., De Ridder, D., Decaestecker, C., & Joniau, S. (2018). Comparing the expression profiles of steroid hormone receptors and stromal cell markers in prostate cancer at different Gleason scores. Scientific reports, 8(1), 14326. doi:10.1038/s41598-018-32711-9
  10. 32. Tosco, L., Laenen, A., Gevaert, T., Salmon, I., Decaestecker, C., Davicioni, E., Buerki, C., Claessens, F., Swinnen, J., Goffin, K., Oyen, R., Everaerts, W., Moris, L., De Meerleer, G., Haustermans, K., Joniau, S., & P.E.A.R.L. (ProstatE cAncer Research Leuven), (2018). Neoadjuvant degarelix with or without apalutamide followed by radical prostatectomy for intermediate and high-risk prostate cancer: ARNEO, a randomized, double blind, placebo-controlled trial. BMC cancer, 18(1), 354. doi:10.1186/s12885-018-4275-z
  11. 33. Roumeguere, T., Legrand, F., El Rassy, E., Idrissi Kaitouni, M., Albisinni, S., Rousseau, A., Vanhaeverbeek, M., Rorive, S., Decaestecker, C., Debeir, O., Zouaoui Boudjeltia, K., & Aoun, F. (2018). A prospective clinical study of the implications of IL-8 in the diagnosis, aggressiveness and prognosis of prostate cancer. Future science OA, 4(2), FSO266. doi:10.4155/fsoa-2017-0084
  12. 34. Fontaine, M., Vogel, I., Van Eycke, Y.-R., Galuppo, A., Ajouaou, Y., Decaestecker, C., Kassiotis, G., Moser, M., & Leo, O. (2018). Regulatory T cells constrain the TCR repertoire of antigen-stimulated conventional CD4 T cells. EMBO journal, 37(3), 398-412. doi:10.15252/embj.201796881

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Suivant >>